Tranexamic Acid

Tranexamic Acid Synonyms: Trans-4-Aminomethylcyclohexane-1-carboxylate; Trans-4-(Aminomethyl)cyclohexanecarboxylic acid; Amstat CAS: 1197-18-8 EINECS No.: 212-818-4 M. F.: C8H15NO2 M.

W.: 157.21 Assay: 99.0-101.0% Apperance: White crystalline Powder Type: Anesthetic Agents Grade Standard: Cosmetic Grade, Medicine Grade PH: 7.0~8.0 Chloride: 140ppm max Loss on drying: 0.5%max Sulfated ash: 0.1%max Use: Hemostatic effect; (for pharmaceutical and cosmetic use) Packing: 1kg Aluminum foil bag or 25kg fiber drum

Specification: Product name: Tranexamic acid Other Name TIMTEC-BB SBB006715;TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID;trans-4-aminomethylcyclohexane-1-carboxylate;TRANS-4-(AMINOMETHYL)CYCLOHEXANECARBOXYLIC ACID;TRANEXAMIC ACID;amstat;amcha;amikapron Original China CAS 1197-18-8 EINECS 212-818-4 Molecular formula C8H15NO2 Molecular Weight 157.21 Brand name NJBNSteroid Delivery time within 24 hours upon receipt of payment Delivery Fast and secure shipping by EMS, DHL, TNT, FedEx, UPS Purity 99% Package Discreet and Hidden package according to specific requirement Appearance White powder Certification SGS, ISO 9001, KOSHER Payment Terms Western Union, Money Gram , T/T, Bitcoin Minimum Order Quantity 10g Price Negotiable Usage Hemostatic effect; (for pharmaceutical and cosmetic use).

MF

Description Tranexamic acid (TXA) is a medication used to treat or prevent excessive blood loss from trauma, surgery, and in various medical conditions including hemophilia and heavy menstrual bleeding. It comes in oral and intravenous forms.

Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule responsible for the degradation of fibrin. Fibrin is the basic framework for the formation of a blood clot in hemostasis.Tranexamic acid has roughly 8 times the antifibrinolytic activity of an older analogue.

Function： A- For fibrinolytic hemorrhages, such as brain, lung, uterine, the prostate gland, adrenal gland, thyroid gland, trauma or surgical bleeding. B- Intraoperative early medication or preoperative medication, can reduce bleeding in the operation, and decrease the amount of blood transfusion.

C- Also used in pulmonary hemorrhage, liver cirrhosis hemorrhage and upper gastrointestinal hemorrhage. D- Used in bleeding caused by fibrinolysis process hyperfunction: Such as abnormal bleeding of operation for the lung, liver, pancreas, prostate, thyroid, adrenal surgery.

Such as obstetrics and postpartum hemorrhage and tuberculosis hemoptysis or blood-stained sputum, hematuria, prostatic hypertrophy bleeding, upper gastrointestinal bleeding, etc. E- Can also be used for bleeding caused by excessive streptokinase or urokinase.

Medical Uses 1.Hemostatic, significant effect on traumatic bleeding, preoperative prophylactic medication can decrease operation hemorrhage. 2.

The chemical structure of tranexamic acid and lysine, competitive inhibition of plasminogen to fibrin adsorption, to prevent their activation, protect the fiber protein was not degraded by the enzyme and dissolved, ultimately achieve hemostasis effect. 3.

All applicable in the treatment of acute or chronic, localized or systemic primary fibrinolysis hyperfunction caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hypertrophy of the prostate, hemophilia hemorrhage, pulmonary tuberculosis hemoptysis, bleeding in the stomach, liver, lung, spleen and other organs of hemorrhage after operation 4.

The clinical effect of tranexamic acid on insect bites, eczema and dermatitis, simple purpura, chronic urticaria, artificial sex urticaria, rash and drug poisoning effect, also have certain effects on erythroderma, scleroderma, SLE, erythema multiforme, herpes zoster and alopecia areata, curative effect of hereditary angioedema is also good.